11/11/2026 | Press release | Archived content
Dr. Joshua Heyza, assistant professor in the Institute of Environmental Health Sciences and Department of Pharmacology at Wayne State University, contributed to a collaborative study, "Cas12a-based combinatorial knockout screens define the genetic architecture of the DNA damage response," published Nov. 6, 2026 in Nature Biotechnology, that maps relationships among DNA damage response genes and examines how the loss of one DNA repair pathway changes cells' dependence on others.
Cells rely on several repair systems to protect their DNA. When one system stops working, another may become essential for survival. To investigate these relationships, a team led by Dr. Alberto Ciccia at Columbia University, by Alberto Ciccia, Ph.D., at Columbia University used CRISPR gene editing to switch off 233 genes involved in responding to DNA damage, both individually and in more than 27,000 pairwise combinations. The researchers identified more than 750 interactions in which the combined effects of losing two genes differed from what would be expected from losing each alone. These findings provide a resource for understanding DNA repair and identifying potential vulnerabilities in cancers with DNA repair defects.
Heyza's contribution builds on his imaging work in a 2023 study published in Science, which provided direct visual evidence that RHINO recruits DNA polymerase θ (Pol θ) to DNA double-strand breaks during mitosis to support repair through microhomology-mediated end joining.
In the current study, Heyza used CRISPR-based endogenous protein tagging and live-cell imaging to help demonstrate why cells with a defect in one repair system, the Fanconi anemia pathway, become dependent on a specific DNA repair pathway that functions during cell division. He introduced a fluorescent tag into the endogenous RHNO1 gene, which encodes RHINO, in cells containing endogenously HaloTagged DNA Pol θ, enabling both repair proteins to be visualized in living cells.
Heyza's imaging helped reveal that cells lacking FANCL, a component of the Fanconi anemia pathway, form more RHINO and Pol θ foci during mitosis, particularly when DNA replication stress is induced. These findings support a model in which GEN1 processes unresolved DNA structures into breaks that are then repaired through a mechanism involving RHINO and Pol θ.
"Our study reveals how defects in the Fanconi anemia pathway create a dependence on DNA repair during cell division," said Heyza. "This research is expanding our understanding of how cells compensate when particular repair pathways fail."
Heyza received his Ph.D. from the Wayne State University School of Medicine in 2019 and did his postdoctoral studies at Michigan State University. He joined Wayne State's Department of Pharmacology and the Institute of Environmental Health Sciences in 2025.
"This is groundbreaking research that will define Dr. Heyza's field for decades to come," said Dr. Sokol Todi, chair of the Department of Pharmacology in the School of Medicine. "We are very proud of him and honored to have him as a member of our faculty body."